We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 5,324 results
  1. Clinical and pathological aspects of toxic myopathies

    As the most frequent cause of acquired myopathy, toxic myopathies are characterised by clinicopathological features that vary depending on the mode...

    Mégane Le Quang, Guilhem Solé, ... Stéphane Mathis in Journal of Neurology
    Article 21 June 2024
  2. Epidemiology of the idiopathic inflammatory myopathies

    The idiopathic inflammatory myopathies (IIMs) are a heterogeneous group of systemic autoimmune diseases that affect the skeletal muscles and can also...

    Thomas Khoo, James B. Lilleker, ... Hector Chinoy in Nature Reviews Rheumatology
    Article 06 October 2023
  3. Idiopathic Inflammatory Myopathies

    Idiopathic inflammatory myopathies (IIMs) are a diverse group of diseases characterized by proximal muscle weakness and inflammation in skeletal...

    Suma Balan, Sumanth Madan in Indian Journal of Pediatrics
    Article 03 November 2023
  4. Cardiovascular manifestations in idiopathic inflammatory myopathies

    Cardiovascular involvement in idiopathic inflammatory myopathies (IIM) is an understudied area which is gaining increasing recognition in recent...

    Meera Shah, Samuel Katsuyuki Shinjo, ... Latika Gupta in Clinical Rheumatology
    Article Open access 06 May 2023
  5. Assessment of cardiovascular risk factors in patients with idiopathic inflammatory myopathies: a systematic review

    We performed a systematic review of cardiovascular risk factors in idiopathic inflammatory myopathies (IIMs) and their cardiovascular outcomes,...

    Jucier Gonçalves Júnior, Samuel Katsuyuki Shinjo in Clinical Rheumatology
    Article 16 May 2023
  6. Intravenous Immunoglobulins in Idiopathic Inflammatory Myopathies: Where Are We?

    Purpose of Review

    Idiopathic inflammatory myopathies (IIM) are a group of heterogeneous autoimmune diseases characterized by muscular but also...

    Kevin Gourbeyre-Masson, Océane Landon-Cardinal, ... Yves Allenbach in Current Treatment Options in Rheumatology
    Article 10 January 2024
  7. Pathogenic role and clinical significance of neutrophils and neutrophil extracellular traps in idiopathic inflammatory myopathies

    Idiopathic inflammatory myopathies (IIM) are a heterogeneous group of chronic autoimmune diseases characterized by muscle damage and extramuscular...

    Ruiting Liu, Hongjiang Liu, ... Qibing **e in Clinical and Experimental Medicine
    Article Open access 30 May 2024
  8. A bibliometric analysis of idiopathic inflammatory myopathies from 1982 to 2021

    Objective

    There has been an increasing number of literature related to idiopathic inflammatory myopathies (IIM) in the past few decades. However,...

    Teng Wu, Jia** Qi, ... Zhenhua Ying in Clinical Rheumatology
    Article 11 November 2022
  9. Effectiveness and safety of mycophenolate mofetil and rituximab combination therapy for immune idiopathic myopathies

    Introduction

    Idiopathic inflammatory myopathies (IIM) represent a rare and heterogenous group diseases, and their treatment is not fully defined yet....

    Corrado Campochiaro, Nicola Farina, ... Lorenzo Dagna in Arthritis Research & Therapy
    Article Open access 03 April 2024
  10. The Role of Environmental Factors in the Development of Idiopathic Inflammatory Myopathies: a Narrative Review

    Purpose of Review

    This review aims to evaluate recent findings on the role of environmental factors in the development and clinical presentation of...

    Shintaro Yamamoto, Akira Yoshida, ... Masataka Kuwana in Current Rheumatology Reports
    Article 16 November 2023
  11. Immune-Mediated Necrotizing Myopathies: Current Landscape

    Purpose of Review

    Immune-mediated necrotizing myopathy (IMNM), characterized by acute or subacute onset, severe weakness, and elevated creatine kinase...

    Christoforos Koumas, Francesco Michelassi in Current Neurology and Neuroscience Reports
    Article 09 April 2024
  12. Impact of SARS-CoV-2 on the clinical presentation of juvenile idiopathic inflammatory myopathies

    Background

    Growing evidence suggests that infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) may trigger idiopathic...

    Jessica Perfetto, Donna A. Yoo, ... Dawn M. Wahezi in Pediatric Rheumatology
    Article Open access 11 August 2023
  13. Inflammatory myopathies overlap** with systemic sclerosis: a systematic review

    We performed a systematic review of the clinical manifestations and complementary exams of patients with myopathies and systemic sclerosis overlap...

    Jucier Gonçalves Júnior, Naoki Mugii, ... Samuel Katsuyuki Shinjo in Clinical Rheumatology
    Article 27 February 2022
  14. Celiac disease prevalence in patients with idiopathic inflammatory myopathies, a cross-sectional study

    Up to 30% of patients with celiac disease (CD) suffer from concurrent autoimmune disease, compared to 3% of the general population. The association...

    Rolando Áyax González-Leal, Jiram Torres-Ruiz, ... Diana Gómez-Martín in Clinical Rheumatology
    Article 06 June 2024
  15. Idiopathic inflammatory myopathies

    Idiopathic inflammatory myopathies (IIM), also known as myositis, are a heterogeneous group of autoimmune disorders with varying clinical...

    Ingrid E. Lundberg, Manabu Fujimoto, ... Frederick W. Miller in Nature Reviews Disease Primers
    Article 02 December 2021
  16. The spectrum of idiopathic inflammatory myopathies in Western Australia: epidemiological characteristics and mortality over time

    To determine long term overall and subgroup specific incidence rates and associated mortality for idiopathic inflammatory myopathies (IIM) in a...

    Johannes Nossent, Helen Keen, ... Charles A. Inderjeeth in Rheumatology International
    Article Open access 11 October 2023
  17. The impact of the COVID-19 pandemic on patients with juvenile idiopathic inflammatory myopathies

    Background

    Throughout the COVID-19 pandemic, there have been concerns regarding the risks of infection in patients with autoimmune disease. In this...

    Dawn M. Wahezi, Dominique Jerome, ... Tamar Rubinstein in Pediatric Rheumatology
    Article Open access 12 September 2023
  18. A protocol for sco** reviews on the role of whole-body and dedicated body-part magnetic resonance imaging for assessment of adult and juvenile idiopathic inflammatory myopathies

    Currently, standardized magnetic resonance imaging (MRI) scoring systems and protocols for assessment of idiopathic inflammatory myopathies (IIMs) in...

    Mickael Essouma, Daniel Brito de Araujo, ... Andrea Schwarz Doria in Rheumatology International
    Article 08 July 2024
  19. Diagnostic yield of multi-gene panel for muscular dystrophies and other hereditary myopathies

    Genetic testing is being considered the first-step in the investigation of hereditary myopathies. However, the performance of the different testing...

    Pablo Brea Winckler, Bruna Cristine Chwal, ... Jonas Alex Morales Saute in Neurological Sciences
    Article 17 February 2022
  20. Clinical and genetic features of infancy-onset congenital myopathies from a Chinese paediatric centre

    Background

    Congenital myopathies are a group of rare neuromuscular diseases characterized by specific histopathological features. The relationship...

    Yu Zhang, Hui Yan, ... **ngzhi Chang in BMC Pediatrics
    Article Open access 26 January 2022
Did you find what you were looking for? Share feedback.